Global Anti-CD20 Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Anti-CD20 Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 First Generation Anti-CD20 Monoclonal Antibody
1.2.3 Second Generation Anti-CD20 Monoclonal Antibody
1.2.4 Third Generation Anti-CD20 Monoclonal Antibody
1.3 Market Segment by Application
1.3.1 Global Anti-CD20 Monoclonal Antibodies Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Anti-CD20 Monoclonal Antibodies Market Size (2017-2028)
2.1.1 Global Anti-CD20 Monoclonal Antibodies Revenue (2017-2028)
2.1.2 Global Anti-CD20 Monoclonal Antibodies Sales (2017-2028)
2.2 Global Anti-CD20 Monoclonal Antibodies Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Anti-CD20 Monoclonal Antibodies Sales by Regions (2017-2022)
2.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Regions (2017-2022)
2.3 Global Anti-CD20 Monoclonal Antibodies Market Size Forecast by Region
2.3.1 Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Region (2023-2028)
2.3.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Region (2023-2028)
2.4 Global Top Anti-CD20 Monoclonal Antibodies Regions (Countries) Ranking by Market Size
2.5 Anti-CD20 Monoclonal Antibodies Market Dynamics
2.5.1 Anti-CD20 Monoclonal Antibodies Market Trends
2.5.2 Anti-CD20 Monoclonal Antibodies Market Drivers
2.5.3 Anti-CD20 Monoclonal Antibodies Market Challenges
2.5.4 Anti-CD20 Monoclonal Antibodies Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Anti-CD20 Monoclonal Antibodies Manufacturers by Sales (2017-2022)
3.1.1 Global Anti-CD20 Monoclonal Antibodies Sales by Manufacturers (2017-2022)
3.1.2 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti-CD20 Monoclonal Antibodies Sales in 2021
3.2 Global Top Manufacturers Anti-CD20 Monoclonal Antibodies by Revenue
3.2.1 Global Anti-CD20 Monoclonal Antibodies Revenue by Manufacturers (2017-2022)
3.2.2 Top Anti-CD20 Monoclonal Antibodies Manufacturers Covered: Ranking by Revenue
3.2.3 Global Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Anti-CD20 Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-CD20 Monoclonal Antibodies as of 2021)
3.4 Global Anti-CD20 Monoclonal Antibodies Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti-CD20 Monoclonal Antibodies Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti-CD20 Monoclonal Antibodies Market
3.7 Key Manufacturers Anti-CD20 Monoclonal Antibodies Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Anti-CD20 Monoclonal Antibodies Market Size by Type
4.1 Global Anti-CD20 Monoclonal Antibodies Historic Market Review by Type (2017-2022)
4.1.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2017-2022)
4.1.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2017-2022)
4.1.3 Anti-CD20 Monoclonal Antibodies Price by Type (2017-2022)
4.2 Global Anti-CD20 Monoclonal Antibodies Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Type (2023-2028)
4.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Type (2023-2028)
4.2.3 Anti-CD20 Monoclonal Antibodies Price Forecast by Type (2023-2028)
5 Global Anti-CD20 Monoclonal Antibodies Market Size by Application
5.1 Global Anti-CD20 Monoclonal Antibodies Historic Market Review by Application (2017-2022)
5.1.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2017-2022)
5.1.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2017-2022)
5.1.3 Anti-CD20 Monoclonal Antibodies Price by Application (2017-2022)
5.2 Global Anti-CD20 Monoclonal Antibodies Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Application (2023-2028)
5.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Application (2023-2028)
5.2.3 Anti-CD20 Monoclonal Antibodies Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-CD20 Monoclonal Antibodies Sales Breakdown by Company
6.1.1 North America Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022)
6.1.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022)
6.2 North America Anti-CD20 Monoclonal Antibodies Market Size by Type
6.2.1 North America Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
6.2.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
6.3 North America Anti-CD20 Monoclonal Antibodies Market Size by Application
6.3.1 North America Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
6.3.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
6.4 North America Anti-CD20 Monoclonal Antibodies Market Size by Country
6.4.1 North America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2028)
6.4.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Anti-CD20 Monoclonal Antibodies Sales Breakdown by Company
7.1.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022)
7.1.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022)
7.2 Europe Anti-CD20 Monoclonal Antibodies Market Size by Type
7.2.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
7.2.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
7.3 Europe Anti-CD20 Monoclonal Antibodies Market Size by Application
7.3.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
7.3.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
7.4 Europe Anti-CD20 Monoclonal Antibodies Market Size by Country
7.4.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2028)
7.4.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Breakdown by Company
8.1.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022)
8.1.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022)
8.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Size by Type
8.2.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
8.2.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
8.3 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Size by Application
8.3.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
8.3.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
8.4 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Size by Region
8.4.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region
8.4.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Anti-CD20 Monoclonal Antibodies Sales Breakdown by Company
9.1.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022)
9.1.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022)
9.2 Latin America Anti-CD20 Monoclonal Antibodies Market Size by Type
9.2.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
9.2.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
9.3 Latin America Anti-CD20 Monoclonal Antibodies Market Size by Application
9.3.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
9.3.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
9.4 Latin America Anti-CD20 Monoclonal Antibodies Market Size by Country
9.4.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2028)
9.4.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales Breakdown by Company
10.1.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022)
10.1.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022)
10.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Size by Type
10.2.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
10.2.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
10.3 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Size by Application
10.3.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
10.3.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
10.4 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Size by Country
10.4.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2028)
10.4.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Genmab
11.1.1 Genmab Corporation Information
11.1.2 Genmab Overview
11.1.3 Genmab Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Genmab Anti-CD20 Monoclonal Antibodies Products and Services
11.1.5 Genmab Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.1.6 Genmab Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Amgen Anti-CD20 Monoclonal Antibodies Products and Services
11.2.5 Amgen Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.2.6 Amgen Recent Developments
11.3 Celltrion
11.3.1 Celltrion Corporation Information
11.3.2 Celltrion Overview
11.3.3 Celltrion Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Celltrion Anti-CD20 Monoclonal Antibodies Products and Services
11.3.5 Celltrion Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.3.6 Celltrion Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Overview
11.4.3 Roche Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Roche Anti-CD20 Monoclonal Antibodies Products and Services
11.4.5 Roche Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.4.6 Roche Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Overview
11.5.3 Novartis AG Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Novartis AG Anti-CD20 Monoclonal Antibodies Products and Services
11.5.5 Novartis AG Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.5.6 Novartis AG Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Pfizer Anti-CD20 Monoclonal Antibodies Products and Services
11.6.5 Pfizer Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Biogen
11.7.1 Biogen Corporation Information
11.7.2 Biogen Overview
11.7.3 Biogen Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Biogen Anti-CD20 Monoclonal Antibodies Products and Services
11.7.5 Biogen Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.7.6 Biogen Recent Developments
11.8 Genentech
11.8.1 Genentech Corporation Information
11.8.2 Genentech Overview
11.8.3 Genentech Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Genentech Anti-CD20 Monoclonal Antibodies Products and Services
11.8.5 Genentech Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.8.6 Genentech Recent Developments
11.9 Immunomedics
11.9.1 Immunomedics Corporation Information
11.9.2 Immunomedics Overview
11.9.3 Immunomedics Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Immunomedics Anti-CD20 Monoclonal Antibodies Products and Services
11.9.5 Immunomedics Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.9.6 Immunomedics Recent Developments
11.10 Spectrum Pharmaceuticals
11.10.1 Spectrum Pharmaceuticals Corporation Information
11.10.2 Spectrum Pharmaceuticals Overview
11.10.3 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Products and Services
11.10.5 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies SWOT Analysis
11.10.6 Spectrum Pharmaceuticals Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Corporation Information
11.11.2 Bio-Rad Laboratories Overview
11.11.3 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Products and Services
11.11.5 Bio-Rad Laboratories Recent Developments
11.12 LFB Biotechnologie
11.12.1 LFB Biotechnologie Corporation Information
11.12.2 LFB Biotechnologie Overview
11.12.3 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Products and Services
11.12.5 LFB Biotechnologie Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Anti-CD20 Monoclonal Antibodies Value Chain Analysis
12.2 Anti-CD20 Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-CD20 Monoclonal Antibodies Production Mode & Process
12.4 Anti-CD20 Monoclonal Antibodies Sales and Marketing
12.4.1 Anti-CD20 Monoclonal Antibodies Sales Channels
12.4.2 Anti-CD20 Monoclonal Antibodies Distributors
12.5 Anti-CD20 Monoclonal Antibodies Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of First Generation Anti-CD20 Monoclonal Antibody
Table 3. Major Manufacturers of Second Generation Anti-CD20 Monoclonal Antibody
Table 4. Major Manufacturers of Third Generation Anti-CD20 Monoclonal Antibody
Table 5. Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Anti-CD20 Monoclonal Antibodies Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Anti-CD20 Monoclonal Antibodies Sales by Region (2017-2022) & (KG)
Table 8. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Table 9. Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
Table 11. Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Region (2023-2028) & (KG)
Table 12. Global Anti-CD20 Monoclonal Antibodies Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Anti-CD20 Monoclonal Antibodies Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Anti-CD20 Monoclonal Antibodies Market Trends
Table 17. Anti-CD20 Monoclonal Antibodies Market Drivers
Table 18. Anti-CD20 Monoclonal Antibodies Market Challenges
Table 19. Anti-CD20 Monoclonal Antibodies Market Restraints
Table 20. Global Anti-CD20 Monoclonal Antibodies Sales by Manufacturers (2017-2022) & (KG)
Table 21. Global Anti-CD20 Monoclonal Antibodies Sales Share by Manufacturers (2017-2022)
Table 22. Global Anti-CD20 Monoclonal Antibodies Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Anti-CD20 Monoclonal Antibodies Manufacturers by Revenue (US$ Million) in 2021
Table 24. Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
Table 25. Global Anti-CD20 Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-CD20 Monoclonal Antibodies as of 2021)
Table 27. Key Manufacturers Anti-CD20 Monoclonal Antibodies Average Selling Price (ASP) & (2017-2022) & (USD/KG)
Table 28. Key Manufacturers Anti-CD20 Monoclonal Antibodies Plants/Factories Distribution
Table 29. Key Manufacturers Anti-CD20 Monoclonal Antibodies Area Served
Table 30. Date of Key Manufacturers Enter into Anti-CD20 Monoclonal Antibodies Market
Table 31. Key Manufacturers Anti-CD20 Monoclonal Antibodies Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2017-2022)
Table 34. Global Anti-CD20 Monoclonal Antibodies Sales Share by Type (2017-2022)
Table 35. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Anti-CD20 Monoclonal Antibodies Price (KG) by Type (2017-2022)
Table 37. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2023-2028)
Table 38. Global Anti-CD20 Monoclonal Antibodies Sales Share by Type (2023-2028)
Table 39. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Type (2023-2028)
Table 41. Global Anti-CD20 Monoclonal Antibodies Price (KG) by Type (2023-2028)
Table 42. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2017-2022)
Table 43. Global Anti-CD20 Monoclonal Antibodies Sales Share by Application (2017-2022)
Table 44. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Anti-CD20 Monoclonal Antibodies Price (KG) by Application (2017-2022)
Table 46. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2023-2028)
Table 47. Global Anti-CD20 Monoclonal Antibodies Sales Share by Application (2023-2028)
Table 48. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Application (2023-2028)
Table 50. Global Anti-CD20 Monoclonal Antibodies Price (KG) by Application (2023-2028)
Table 51. North America Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022) & (KG)
Table 52. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 53. North America Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 55. North America Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 56. North America Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 57. North America Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 60. North America Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 61. North America Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 64. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2023-2028) & (KG)
Table 65. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022) & (KG)
Table 68. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 69. Europe Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Anti-CD20 Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 71. Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 72. Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 73. Europe Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 76. Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 77. Europe Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 80. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2023-2028) & (KG)
Table 81. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022) & (KG)
Table 84. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 88. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 89. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 92. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 93. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2017-2022) & (KG)
Table 96. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2023-2028) & (KG)
Table 97. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022) & (KG)
Table 100. Latin America Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 101. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 103. Latin America Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 104. Latin America Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 105. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 108. Latin America Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 109. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 112. Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2023-2028) & (KG)
Table 113. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Company (2017-2022) & (KG)
Table 116. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 120. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 121. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 124. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 125. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 128. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2023-2028) & (KG)
Table 129. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 131. Genmab Corporation Information
Table 132. Genmab Description and Overview
Table 133. Genmab Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 134. Genmab Anti-CD20 Monoclonal Antibodies Product and Services
Table 135. Genmab Anti-CD20 Monoclonal Antibodies SWOT Analysis
Table 136. Genmab Recent Developments
Table 137. Amgen Corporation Information
Table 138. Amgen Description and Overview
Table 139. Amgen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 140. Amgen Anti-CD20 Monoclonal Antibodies Product and Services
Table 141. Amgen Anti-CD20 Monoclonal Antibodies SWOT Analysis
Table 142. Amgen Recent Developments
Table 143. Celltrion Corporation Information
Table 144. Celltrion Description and Overview
Table 145. Celltrion Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 146. Celltrion Anti-CD20 Monoclonal Antibodies Product and Services
Table 147. Celltrion Anti-CD20 Monoclonal Antibodies SWOT Analysis
Table 148. Celltrion Recent Developments
Table 149. Roche Corporation Information
Table 150. Roche Description and Overview
Table 151. Roche Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 152. Roche Anti-CD20 Monoclonal Antibodies Product and Services
Table 153. Roche Anti-CD20 Monoclonal Antibodies SWOT Analysis
Table 154. Roche Recent Developments
Table 155. Novartis AG Corporation Information
Table 156. Novartis AG Description and Overview
Table 157. Novartis AG Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 158. Novartis AG Anti-CD20 Monoclonal Antibodies Product and Services
Table 159. Novartis AG Anti-CD20 Monoclonal Antibodies SWOT Analysis
Table 160. Novartis AG Recent Developments
Table 161. Pfizer Corporation Information
Table 162. Pfizer Description and Overview
Table 163. Pfizer Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 164. Pfizer Anti-CD20 Monoclonal Antibodies Product and Services
Table 165. Pfizer Anti-CD20 Monoclonal Antibodies SWOT Analysis
Table 166. Pfizer Recent Developments
Table 167. Biogen Corporation Information
Table 168. Biogen Description and Overview
Table 169. Biogen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 1

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antibody Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136

According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Antibody Production Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121

Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......

Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......

Global Antibody Production Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......

Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Monoclonal Antibody Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92

This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......

Monoclonal Antibody Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73

This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......

Monoclonal Antibody Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219

China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs